Display options
Cite
Honeycutt A, Breck A, Bass S, et al. Impact analysis of expanding anti-TNF therapy for Crohn's disease. J Comp Eff Res. 2022;doi: 10.2217/cer-2021-0063.
Honeycutt, A., Breck, A., Bass, S., & Esposito, D. (2022). Impact analysis of expanding anti-TNF therapy for Crohn's disease. Journal of comparative effectiveness research, . https://doi.org/10.2217/cer-2021-0063
Honeycutt, Amanda, et al. "Impact analysis of expanding anti-TNF therapy for Crohn's disease." Journal of comparative effectiveness research vol. (2022). doi: https://doi.org/10.2217/cer-2021-0063
Honeycutt A, Breck A, Bass S, Esposito D. Impact analysis of expanding anti-TNF therapy for Crohn's disease. J Comp Eff Res. 2022 Jan 11; doi: 10.2217/cer-2021-0063. Epub 2022 Jan 11. PMID: 35014551.
Copy Download .nbib Format: NLM
Share it on

J Comp Eff Res. 2022 Jan 11; doi: 10.2217/cer-2021-0063. Epub 2022 Jan 11.

Impact analysis of expanding anti-TNF therapy for Crohn's disease.

Journal of comparative effectiveness research

Amanda Honeycutt, Andrew Breck, Sarah Bass, Dominick Esposito

Affiliations

  1. RTI International, Health Economics Program, Research Triangle Park, Durham, NC 27709-2194, USA.
  2. Insight Policy Research, Arlington, VA 22209, USA.

PMID: 35014551 DOI: 10.2217/cer-2021-0063

[No abstract available.]

Keywords: Crohn’s disease; Markov model; anti-TNF; healthcare expenditures; inflammatory bowel disease

Publication Types

Grant support